SEC Form 4 · accession 0001651844-18-000031
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Dec 6, 2018
Accepted (ET)
Dec 7, 2018 · 2:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 6, 2018 | P | 1,400 | $1.74 | A | 3,279,813 | D |
Table II — derivative securities
No Table II lines on this filing.